Latest News

STAT Plus: Intermountain, Amgen subsidiary to launch DNA study of 500,000 patients

Utah-based Intermountain Healthcare and the Icelandic company deCODE Genetics are teaming up on a deep dive into the DNA of half a million patients, a collaboration they hope can reveal connections between the makeup of our genomes and our health.

The partnership, announced Wednesday and dubbed the HerediGene: Population Study, aims to analyze the genomes of 500,000 patients from Intermountain’s network of clinics and hospitals in Utah and Idaho. Scientists and clinical experts from deCODE and Intermountain will compare the genomic data with patients’ medical histories to gain a better understanding of how our genes influence our health.

Continue to STAT Plus to read the full story…

Source link




Related posts

Pain Assessment in INTensive care (PAINT): an observational study of physician-documented pain assessment in 45 intensive care units in the United Kingdom

Newsemia

NanOlogy™发布吸入NanoPac治疗肺癌的阳性临床前数据

Newsemia

Forgiveness Reduces Blood Pressure, Improves Physiological Health, Studies Claim

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy